慢乙肝治疗的指南和共识的回顾
——  作者:    时间:2008-08-06     阅读数: 561

简介:Interferon-based or judicious use of NA in compensated disease, appropriate rescue for drug resistance; continue NA(s) till after 6M HBeAg seroconversion (HBeAg+ CHB), HBsAg clearance (HBeAg – CHB).Protracted severe acute hepatitis B (INR increase and deep jaundice > 4M) treat with lamivudine, telbivudine or entecavir till HBsAg clearance or indefinite if OLT.

请登录后查看详细内容

发表评论

全部评论